Perspective Therapeutics (CATX) Finished Goods (2011 - 2023)

Perspective Therapeutics (CATX) has 11 years of Finished Goods data on file, last reported at $20000.0 in Q3 2023.

• For the quarter ending Q3 2023, Finished Goods fell 25.93% year-over-year to $20000.0; the trailing twelve-month figure through Sep 2023 stood at $20000.0 (down 25.93% YoY), and the FY2022 full-year result was $21000.0, changed N/A from the prior year.
• Finished Goods advanced to $20000.0 in Q3 2023, from $18000.0 in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $49000.0 in Q2 2021 to a low of $7000.0 in Q4 2019.
• A 5-year average of $22368.4 and a median of $21000.0 in 2022 frame the typical range for Finished Goods.
• Across the five-year window, Finished Goods plunged 72.97% in 2019 and jumped 314.29% in 2021, its largest moves.
• Tracing CATX's Finished Goods over 5 years: stood at $7000.0 in 2019, then changed by 0.0% to $7000.0 in 2020, then jumped by 314.29% to $29000.0 in 2021, then declined by 27.59% to $21000.0 in 2022, then fell by 4.76% to $20000.0 in 2023.
• Business Quant data shows CATX's Finished Goods at $20000.0 in Q3 2023, $18000.0 in Q2 2023, and $15000.0 in Q1 2023.